Results 1 - 20 of 851.
1 2 3 4 5 ... 43 Next »

Pharmacology - Health - 12.07.2024
Biomarkers reveal how patients with glaucoma may respond to treatment
Markers in the blood that predict whether glaucoma patients are at higher risk of continued loss of vision following conventional treatment have been identified by researchers at UCL and Moorfields Eye Hospital. Over 700,000 people in the UK have glaucoma and it is the leading cause of irreversible blindness worldwide.

Health - Pharmacology - 10.07.2024
Cancer experts outline critical challenges facing the new UK Government
Leading doctors and researchers have warned critical challenges in cancer care in the UK need to be urgently addressed by policymakers. In a review published in The Lancet Oncology , a team of UK cancer care professionals has outlined ten time-critical issues impacting the delivery of cancer care services by the NHS.

Health - Pharmacology - 08.07.2024
AI able to identify drug-resistant typhoid-like infection from microscopy images in matter of hours
AI able to identify drug-resistant typhoid-like infection from microscopy images in matter of hours
Artificial intelligence (AI) could be used to identify drug resistant infections, significantly reducing the time taken for a correct diagnosis, Cambridge researchers have shown. The team showed that an algorithm could be trained to identify drug-resistant bacteria correctly from microscopy images alone.

Health - Pharmacology - 27.06.2024
Healthcare Workers at Risk: Gaps in Measles Immunity Exposed
One in five UK healthcare workers may not be fully immunised against measles, new research has found. In a letter published in The Lancet, a team of immunology experts led by Professor Alex Richter at the University of Birmingham examined measles immunity in two groups of healthcare workers (HCWs). The findings revealed that among a cohort of more than 400 HCWs, 13% of participants lacked measles antibodies, with a further 7.5% had borderline antibody status.

Pharmacology - Health - 26.06.2024
Hope for long-term antidepressant users as study shows half can taper off drugs with simple support
Hope for long-term antidepressant users as study shows half can taper off drugs with simple support
Hope for long-term antidepressant users as study shows half can come off drugs with simple support Nearly half of long-term antidepressant users can quit the drugs with GP support and access to internet or telephone helplines alone, a study has revealed. Scientists found that more than 40 per cent of people who were well and not at risk of relapse managed to come off the medication with advice from their doctors.

Health - Pharmacology - 19.06.2024
Imperial’s human challenge study helps explain why some people don’t get COVID
New analysis based on Imperial's COVID-19 human challenge study has helped to uncover how some people avoid getting sick. Researchers have found that people who are able to fend off the SARS-CoV-2 virus have unique immune responses which help them to avoid sustained infection. The findings , which are based on samples obtained from the Imperial-led COVID-19 human challenge study, suggest that a localised immune response in the lining of the nose enables individuals to identify the virus and stop it from gaining a foothold to cause infection.

Health - Pharmacology - 19.06.2024
Immune response study explains why some people don’t get Covid
High levels of a key gene in volunteers who managed to fight off infection quickly suggests it has a protective effect against SARS-CoV-2, according to a new study from researchers at UCL, the Wellcome Sanger Institute and Imperial College London. The study, published in Nature , provides the most detailed view of how the body responds when exposed to an infectious disease.

Pharmacology - 18.06.2024
Psoriasis Probe shows high level of arthritis symptoms in patients
Psoriasis Probe shows high level of arthritis symptoms in patients
Early results of an international study examining the risk of arthritis for people with psoriasis have shown a high burden of joint symptoms in 712 patients - 25% of the total studied so far. But the team are still on the hunt for 2,000 more patients with psoriasis, a condition that causes flaky patches of skin covered with white scales which affects about 3% of people in the UK and Europe.

Health - Pharmacology - 12.06.2024
New research centre aims to improve heart disease treatment
A new research collaboration is setting out to develop computational tools to improve treatments for one of the world's most common causes of death. The University of Glasgow will lead the newly-established EPSRC Centre for Future PCI Planning, which aims to improve outcomes from a frequently-performed treatment for heart artery disease.

Pharmacology - Health - 07.06.2024
Study claiming antidepressant withdrawal is uncommon fails to account for long term users
Study claiming antidepressant withdrawal is uncommon fails to account for long term users
Comment: Study claiming antidepressant withdrawal is uncommon fails to account for long term users Writing in The Conversation, Professor Joanna Moncrieff and Dr Mark Horowitz (both UCL Psychiatry) respond to new research that antidepressant withdrawal is less common than previously thought by highlighting the risks among long-term users.

Health - Pharmacology - 07.06.2024
Major cause of inflammatory bowel disease discovered
UK researchers have discovered a new biological pathway which drives inflammatory bowel disease (IBD) and could be targeted with existing drugs. The work, carried out by researchers at the Francis Crick Institute, working with UCL and Imperial College London, uncovered a region of DNA which effectively dials up the activity of specific white blood cells, driving inflammation and increasing IBD risk.

Health - Pharmacology - 06.06.2024
Major cause of inflammatory bowel disease discovered
Major cause of inflammatory bowel disease discovered
A new biological pathway that is a principal driver of inflammatory bowel disease (IBD) and related conditions, and which can be targeted using existing drugs, has been discovered by researchers at UCL, the Francis Crick Institute and Imperial College London. About 5% of the world's population, and one in ten people in the UK, are currently affected by an autoimmune disease, such as IBD, the umbrella term for Crohn's disease and ulcerative colitis, which cause swelling and irritation of the digestive tract.

Health - Pharmacology - 30.05.2024
New immunotherapy could treat cancer in the bone
A new type of immunotherapy, developed by UCL researchers, has shown promising preclinical results against a bone cancer called osteosarcoma, as part of a study in mice. Osteosarcoma is the most common bone cancer in teenagers but is still relatively rare, with around 160 new cases each year in the UK.

Pharmacology - 20.05.2024
How beeswax could help families in warzones
Beeswax and local herbs could be crucial in helping families living in conflict zones store food, according to scientists from Cardiff University and Kharkiv Polytechnic Institute of National Technical University, Ukraine.

Pharmacology - 16.05.2024
Scientists brew killer bee beer
A new beer is being brewed by microbiologists, using extracts found in killer bees from Namibia. Scientists from Cardiff University have used brewer's yeast that resides in the gut microbiome of killer honeybees in Namibia and applied it to develop a unique craft beer. The Cardiff microbiologists originally visited Namibia as part of a project that unites Cardiff University and the University of Namibia for sustainable environmental development, when the scientists became interested in the Africanised honey bee - also known as the killer bee.

Health - Pharmacology - 14.05.2024
’Weight loss’ drug semaglutide linked to better heart health
The weight loss drug semaglutide delivers cardiovascular benefits irrespective of starting weight and amount of weight lost, according to preliminary findings from a UCL-led research team. The findings, presented at this year's European Congress on Obesity (ECO), suggest that even people with mild obesity or those not losing weight are likely to gain some cardiovascular advantage.

Health - Pharmacology - 13.05.2024
Birth by C-section more than doubles odds of measles vaccine failure
Researchers say it is vital that children born by caesarean section receive two doses of the measles vaccine for robust protection against the disease. A study by the University of Cambridge, UK, and Fudan University, China, has found that a single dose of the measles jab is up to 2.6 times more likely to be completely ineffective in children born by C-section, compared to those born naturally.

Health - Pharmacology - 12.05.2024
Heart failure device could remotely monitor patients and prevent hospitalisation
A brand-new monitoring device for patients with heart failure may be able to detect signs of fluid overload, and could be used to monitor patients and help prevent hospital admissions, according to a new study.

Health - Pharmacology - 08.05.2024
A third Covid vaccine dose improves defence for some clinically extremely vulnerable patients
A major clinical trial has found that an additional COVID 19 vaccine dose led to the majority of clinically extremely vulnerable people mounting defensive antibodies against Covid-19. New research published in The Lancet Rheumatology from the OCTAVE DUO research trial co-led by the University of Birmingham and University of Glasgow found that vaccine boosters led to improved antibody responses among many groups of immunocompromised and immunosuppressed patients.

Health - Pharmacology - 06.05.2024
New vaccine effective against coronaviruses that haven’t even emerged yet
Researchers have developed a new vaccine technology that has been shown in mice to provide protection against a broad range of coronaviruses with potential for future disease outbreaks - including ones we don't even know about Our focus is to create a vaccine that will protect us against the next coronavirus pandemic, and have it ready before the pandemic has even started.
1 2 3 4 5 ... 43 Next »